Pharmaceutical

Japan grants patent for BioArctic’s Parkinson’s disease antibody

Japan has granted a new drug substance patent for BioArctic’s monoclonal antibody (mAb), BAN0805, to treat Parkinson’s disease.

Aug 24, 2023 - 20:00
Japan grants patent for BioArctic’s Parkinson’s disease antibody
Japan has granted a new drug substance patent for BioArctic’s monoclonal antibody (mAb), BAN0805, to treat Parkinson’s disease.
Read the original article

Tags:

Previous Article

FORE Biotherapeutics raises funding to expedite plixorafenib development

Next Article

Dizal receives approval in China for NSCLC therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Ron DeSantis wants to import drugs from Canada. Biden’s FDA just blasted his plan

STAT+: Ron DeSantis wants to import drugs from Canada. ...

Aug 23, 2023

Opinion: Pumping milk at JPM was a nightmare. It’s part of a bigger problem in the industry

Opinion: Pumping milk at JPM was a nightmare. It’s part...

Jan 12, 2024

AION Labs and BioMed X launch sixth challenge for AI-driven drug discovery

AION Labs and BioMed X launch sixth challenge for AI-dr...

May 30, 2023